Dev

A systems pharmacology approach to the discovery of novel therapeutics in Alzheimer´s disease Investments > €500k European Commission Alzheimer’s disease & other dementias 2016    

The Molecular Anatomy of Neurons Investments > €500k European Commission Alzheimer’s disease & other dementias|Parkinson’s disease & PD-related disorders 2016    

Biomarker Development for Postoperative Cognitive Impairment in the Elderly Investments > €500k European Commission Alzheimer’s disease & other dementias 2016    

Molecular mechanism of amyloid beta aggregation Investments > €500k European Commission Alzheimer’s disease & other dementias 2016    

Development and application of global lipidomic arrays to inflammatory vascular disease. Investments > €500k European Commission Alzheimer’s disease & other dementias 2016    

Fast transformation between episodic and semantic memories: Interactions between the hippocampal formation and related regions and their breakdown in Alzheimer’s disease Investments > €500k European Commission Alzheimer’s disease & other dementias 2016    

METABOLIC BASIS OF NEURODEGENERATIVE DISEASE Investments > €500k European Commission Alzheimer’s disease & other dementias 2016    

The analysis of mitochondrial dynamics in ageing and neurodegeneration Investments > €500k European Commission Neurodegenerative disease in general 2016    

Aetionomy: Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug Development and Therapy Investments > €500k European Commission Alzheimer’s disease & other dementias|Parkinson’s disease & PD-related disorders 2016    

Closing the Loop between Understanding and Effective Treatment of the Basal Ganglia and their Disorders Investments > €500k European Commission Parkinson’s disease & PD-related disorders 2016